These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8219920)

  • 1. Drugs of abuse in urine: some pitfalls in testing.
    Bosomworth MP
    Br J Biomed Sci; 1993 Jun; 50(2):150-5. PubMed ID: 8219920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization and cost effectiveness of standardized testing for screening and confirmation of drugs of abuse in urine.
    Lum G
    Ann Clin Lab Sci; 2002; 32(4):387-92. PubMed ID: 12458891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing urine for drugs.
    Catlin DH; Cowan D; Donike M; Fraisse D; Oftebro H; Rendic S
    Ann Biol Clin (Paris); 1992; 50(5):359-66. PubMed ID: 1485694
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gas chromatography/mass spectrometry. Instrumental techniques in forensic urine drug testing.
    Lehrer M
    Clin Lab Med; 1998 Dec; 18(4):631-49. PubMed ID: 9891603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
    George S; Braithwaite RA
    Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs of abuse testing in a psychiatric outpatient service.
    Shearer DS; Baciewicz GJ; Kwong TC
    Clin Lab Med; 1998 Dec; 18(4):713-26. PubMed ID: 9891610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a clinically relevant liquid chromatography tandem mass spectrometry assay for 13 drugs of abuse in urine, designed to meet the needs of the service users.
    Duxbury K; Romagnoli C; Anderson M; Watts R; Waite G
    Ann Clin Biochem; 2010 Sep; 47(Pt 5):415-22. PubMed ID: 20595401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine.
    Dasgupta A
    Am J Clin Pathol; 2007 Sep; 128(3):491-503. PubMed ID: 17709324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology and drugs of abuse testing at the point of care.
    Yang JM
    Clin Lab Med; 2001 Jun; 21(2):363-74, ix-x. PubMed ID: 11396089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine drug testing for social service agencies. A Canadian experience.
    Fraser AD
    Clin Lab Med; 1998 Dec; 18(4):705-11. PubMed ID: 9891609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of immunoassays for urine drug testing.
    Melanson SE
    Clin Lab Med; 2012 Sep; 32(3):429-47. PubMed ID: 22939301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-of-abuse testing at the point of care.
    Melanson SE
    Clin Lab Med; 2009 Sep; 29(3):503-9. PubMed ID: 19840683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug testing in the workplace.
    Phan HM; Yoshizuka K; Murry DJ; Perry PJ
    Pharmacotherapy; 2012 Jul; 32(7):649-56. PubMed ID: 22605533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Procedural aspects and interpretation problems in the analysis of drugs of abuse].
    Mancinelli R; Guiducci MS
    Ann Ist Super Sanita; 2002; 38(3):305-13. PubMed ID: 12645182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunochemical screening: manipulation, handling and interpretation errors, exemplified by benzodiazepines].
    Schütz H; Verhoff MA; Erdmann F; Weiler G
    Arch Kriminol; 2003; 212(5-6):141-50. PubMed ID: 14723121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.